🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Fulgent Genetics, Inc.

FLGT Healthcare
$15.02 +$0.22 (1.52%)
Market Cap: $433.39 M
Gurus Holding
3
Popularity Rank
#3005
% of Shares Held
1.51%
Net Activity (Q4 2025)
-$2.81 M

Guru Ownership Trend

Guru Analysis for Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics, Inc. (FLGT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.55 M.

Top institutional holders include Steven Cohen and Paul Tudor Jones.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $2.81 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Steven Cohen reduced exposure by 36.2%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$2.18 M
Total Buy Value
New Buys 1
Additions 0
-$4.98 M
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
2
Net Buyers
1

FAQs for Fulgent Genetics, Inc. (FLGT)

Major holders include Steven Cohen ($6.22 M), Paul Tudor Jones ($3.05 M), Renaissance Technologies (RenTech) ($2.18 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 435,866 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $2.81 M, with 1 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited FLGT. The total reported sell value was $4.98 M.

Yes, 1 managers opened new positions in FLGT, and 0 increased their existing holdings. The total reported buy value was $2.18 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Reduce -36.2% 236,954 $6.22 M Q4 2025
0.01% Reduce -32.3% 116,048 $3.05 M Q4 2025
0.00% New Buy 82,864 $2.18 M Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form